China’s Ping An Insurance posts 48.9% rise in Q1 profit
BEIJING (Reuters) – Ping An Insurance (Group) Co of China Ltd saw a 48.9% rise in first-quarter net profit as…
Health
Roche Q1 sales decline tempered by swift uptake of new eye drug
By Ludwig Burger (Reuters) -Switzerland’s Roche said first-quarter sales dropped 7% on falling demand for its COVID-19 therapies and tests,…
GSK stays strong as healthy sales beat expectations
By Natalie Grover and Maggie Fick LONDON (Reuters) -GSK began 2023 with a quarterly performance that beat analyst expectations and…
UK sees record sickness and zero productivity growth in 2022
By David Milliken LONDON (Reuters) – Britain saw a record number of working days lost due to short-term sickness last…
White House hopeful Nikki Haley courts moderate Republicans on abortion
By Gram Slattery ARLINGTON, Virginia (Reuters) -Former South Carolina Governor Nikki Haley said on Tuesday she was personally against abortion…
US FDA approves Biogen’s ALS drug
By Raghav Mahobe and Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration said on Tuesday it had approved Biogen…
Biden should sanction Huawei Cloud, other Chinese firms -senators
By David Shepardson WASHINGTON (Reuters) – A group of nine Republican senators on Tuesday urged the Biden administration to impose…
Biogen trims pipeline programs to cut costs, focus on Alzheimer’s drug launch
By Sriparna Roy and Bhanvi Satija (Reuters) – Biogen Inc said on Tuesday it will pause or discontinue at least…
Sudan resident ‘trying to survive’ as food runs out
By Eleanor Whalley (Reuters) – After more than a week of conflict in Sudan, Bandar Dowelbait said his food supplies…
Factbox-Reaction to Biden’s 2024 re-election campaign launch
WASHINGTON (Reuters) – U.S. President Joe Biden on Tuesday formally launched his 2024 re-election bid, promising protection against right-wing extremists…